Issue Preview
BACK TO TOP
2024 Winner
ZymIQ
Recognised Leaders in Smart Enzyme Research 2024
About
ZymIQ
ZymIQ was founded in 2020 by scientists, veterinarians, and entrepreneurs, with the mission to develop innovative enzyme-based therapeutics, cosmetics, and antibiotics for humans and animals. Leveraging enzyme and phage technology, ZymIQ pioneer antimicrobial solutions to address the challenge of increased antibiotic resistance. Headquarters in Sweden with offices in USA, Singapore, Malaysia.
Launched brands:
-DentaPrev: oral health
-Kalzyme: animal health
-fjör: advanced cosmetic (partnership)